Johnson & Johnson is in talks with multiple governments and global organisations as it seeks to develop a Covid-19 vaccine, it said after Reuters reported that the US company is in talks over a potential EU supply deal.

“We are committed to making our Covid-19 vaccine accessible globally to populations at greatest risk and where it could provide the greatest good according to our vaccine’s profile,” a spokesman for the company said in an email.

“As part of that, we are in ongoing discussions with many stakeholders, including national governments and global organisations.”